Short-term efficacy of 1-month and 3-month gonadotropin-releasing hormone agonist depots in girls with central precocious puberty
Purpose Gonadotropin-releasing hormone agonist (GnRHa) has been the mainstay of central precocious puberty (CPP) treatment for decades, but few reports have compared the efficacy of 1-month and 3-month depot GnRHa formulations. This study investigates the short-term efficacy of 1-month and 3-month G...
Main Authors: | Min Jin Jeon, Jae Won Choe, Hye Rim Chung, Jae Hyun Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society of Pediatric Endocrinology
2021-09-01
|
Series: | Annals of Pediatric Endocrinology & Metabolism |
Subjects: | |
Online Access: | http://e-apem.org/upload/pdf/apem-2040134-067.pdf |
Similar Items
-
Effect of gonadotropin-releasing hormone agonist treatment on near final height in girls with central precocious puberty and early puberty
by: Eun Hye Yang, et al.
Published: (2023-03-01) -
Treatment outcomes of gonadotropin-releasing hormone agonist in obese girls with central precocious puberty
by: Hye Ryun Kim, et al.
Published: (2017-12-01) -
The influence of gonadotropin-releasing hormone agonists on anthropometric change in girls with central precocious puberty
by: Jong Wan Yoon, et al.
Published: (2017-12-01) -
Comparison of the effect of gonadotropin-releasing hormone agonist dosage in girls with central precocious puberty
by: Shinyoung Jang, et al.
Published: (2023-02-01) -
Treatment with Depot Leuprolide Acetate in Girls with Idiopathic Precocious Puberty: What Parameter should be Used in Deciding on the Initial Dose?
by: Doğuş Vurallı, et al.
Published: (2020-03-01)